When buying Vilon for liver support investigations, laboratory researchers require verified purity, sequence integrity, and strict endotoxin control. Vilon (Lys-Glu) is a synthetic ultrashort peptide bioregulator evaluated in preclinical models for its ability to modulate chromatin accessibility, regulate hepatocyte expression, and preserve hepatic parenchyma under metabolic or toxic stress.
When buying Vilon for liver support investigations, laboratory researchers require verified purity, sequence integrity, and strict endotoxin control. Vilon (Lys-Glu) is a synthetic ultrashort peptide bioregulator evaluated in preclinical models for its ability to modulate chromatin accessibility, regulate hepatocyte expression, and preserve hepatic parenchyma under metabolic or toxic stress.
Vilon is a synthetic dipeptide composed of L-lysine and L-glutamic acid (Lys-Glu). Originally identified during investigations into peptide-mediated epigenetic control, Vilon belongs to the class of short bioregulatory peptides pioneered in peptide aging and tissue regeneration studies. In laboratory settings, Vilon is primarily utilized to explore how low-molecular-weight peptide signals interact with nuclear structures and gene expression pathways in mammalian tissues.
While short peptides are frequently investigated for systemic immune or endocrine effects, preclinical focus has increasingly centered on Vilon’s influence within hepatic tissue. Researchers evaluating cell survival, structural integrity, and metabolic function in liver models frequently select Vilon due to its well-characterized molecular weight, structural simplicity, and high stability when reconstituted in standardized laboratory buffers. Laboratories seeking to buy Vilon for liver support research can obtain high-purity, batch-verified vials from PX1 Research for in vitro and preclinical assay protocols.
The primary mechanism of action attributed to Vilon involves direct or indirect interactions with nuclear chromatin. In vitro assays utilizing cultured hepatocytes and lymphocytes demonstrate that the Lys-Glu sequence is capable of penetrating nuclear membranes and binding selectively to specific promoter regions of DNA or histone complexes. This binding promotes chromatin decondensation (unraveling), increasing the accessibility of transcription factors to genes associated with cellular repair and protein synthesis.
Preclinical genomic profiling indicates that Vilon administration in cellular models modulates the transcription of genes regulating ribosomal RNA synthesis, antioxidant defense networks, and structural proteins. By stabilizing heterochromatin structure in aging or damaged hepatocytes, Vilon appears to mitigate age-associated transcription drift and cellular senescence. These nuclear interactions make Vilon a valuable probe for investigating epigenetic modulation without the genomic toxicity sometimes associated with larger recombinant proteins or viral vectors.
In animal models of hepatic injury, toxic challenge, or accelerated aging, short peptides like Vilon have demonstrated significant protective and regenerative signaling profiles. Rodent studies evaluating chemical-induced hepatotoxicity show that pre-treatment or concurrent administration of Lys-Glu attenuation marker enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, indicating reduced hepatocyte lysis.
Histological examinations in preclinical trial literature further report that Vilon supports the maintenance of hepatic parenchyma architecture, reducing necrotic foci and collagen deposition following metabolic stress. In vitro cultures of primary hepatocytes treated with Vilon exhibit enhanced protein synthesis rates and improved survival metrics under hypoxic or oxidative challenges. Researchers can explore broader background literature on short-chain bioregulators within the PX1 peptide research library.
The liver functions not only as a metabolic center but also as a primary immune organ housing resident Kupffer cells, sinusoidal endothelial cells, and intrahepatic lymphocytes. Preclinical literature reveals that Vilon modulates signaling across the immune-hepatic axis by normalizing cytokine production and supporting T-cell differentiation dynamics.
In rodent models of immune dysregulation and systemic inflammation, Vilon exposure restored balanced interleukin-2 (IL-2) and interferon-gamma (IFN-γ) expression patterns. By dampening excessive pro-inflammatory cascades while supporting basal immune surveillance, Vilon helps maintain a homeostatic microenvironment within hepatic sinusoids. This dual metabolic and immunomodulatory activity makes Vilon an important candidate for complex co-culture studies involving hepatocytes and non-parenchymal immune populations.
To contextualize Vilon within peptide research, it is essential to compare its profile with related short-chain bioregulators evaluated for tissue restoration and epigenetic regulation. The table below details structural and functional distinctions among prominent laboratory compounds in this class.
Researchers constructing multi-arm trials often pair Vilon with complementary bioregulators to evaluate additive or synergistic signaling pathways in aging or metabolic models. For instance, combining Vilon with Epitalon research studies allows investigators to concurrently observe hepatic gene expression alongside telomerase activation dynamics.
Similarly, comparative assays between Vilon and Thymogen research compounds provide critical data on how dipeptide sequences (Lys-Glu vs. Glu-Trp) differentially govern nuclear gene target selection in immune versus parenchymal cells. Researchers can examine PX1's full catalog of research peptides to select matched purity batches for head-to-head comparative research protocols.
Because small dipeptides present unique analytical challenges during synthesis—such as potential racemization or incomplete coupling—laboratory procurement teams must strictly evaluate supplier analytical data before purchase. Substandard peptides with residual trifluoroacetic acid (TFA), organic solvents, or high bacterial endotoxin levels can artifactually skew hepatocyte viability assays and gene expression panels.
PX1 Research enforces rigorous quality assurance standards for every lot of Vilon manufactured in our USA facilities. Every batch undergoes mandatory third-party verification, including High-Performance Liquid Chromatography (RP-HPLC) to confirm purity exceeding 98.0%, Mass Spectrometry (MS) to verify molecular weight, and chromogenic LAL assays to ensure low endotoxin content (<0.01 EU/mg).
PX1 Research operates as a dedicated supplier for institutional, academic, and private research laboratories requiring dependable, fully documented biochemical reagents. Our operational differentiators include:
- **USA Manufacturing:** Synthesized under strict process control protocols in domestic GMP-compliant facilities.
- **Independent Laboratory Certification:** Every product batch is analyzed by an ISO 17025 accredited testing laboratory.
- **Comprehensive Lot Documentation:** Accessible Certificates of Analysis (COA) containing raw HPLC chromatograms and mass spectra for complete audit compliance.
- **Low Endotoxin Thresholds:** Validated low-endotoxin specifications essential for sensitive cell culture and in vivo rodent models.
- **Rapid Supply Chain Execution:** Same-day dispatch from strategic fulfillment centers in California and Arizona for orders placed Monday through Friday.
Vilon is supplied as a sterile, lyophilized white powder in sealed glass vials. To maintain peptide integrity and ensure reproducible assay results, research personnel should follow established laboratory handling standards:
1. **Reconstitution Buffer Selection:** Reconstitute lyophilized Vilon using sterile Bacteriostatic Water (0.9% benzyl alcohol) for multi-use laboratory bench work or sterile Phosphate-Buffered Saline (PBS, pH 7.4) for sensitive cell culture media applications.
2. **Reconstitution Technique:** Allow the vial to equalize to room temperature prior to reconstitution. Direct the solvent stream down the inner glass wall of the vial. Gently swirl or invert the container until dissolved. Never vortex vigorously, as shear forces may disrupt peptide stability.
3. **Storage Parameters:** Store lyophilized powder at -20°C in a desiccated environment, stable for up to 24 months. Post-reconstitution, store liquid solutions at 4°C for short-term experimentation (up to 7 days) or aliquot into single-use working volumes and freeze at -80°C to prevent degradation from freeze-thaw cycles.
Principal investigators managing high-volume screening programs can submit a bulk research account application to coordinate batch reservations and volume pricing.
What is the sequence and chemical structure of Vilon?
Vilon is a synthetic dipeptide with the amino acid sequence Lysyl-Glutamic acid (Lys-Glu, L-lysyl-L-glutamic acid), with a molecular formula of C11H21N3O5 and a molecular weight of approximately 275.3 g/mol.
What is Vilon studied for in preclinical laboratory settings?
Vilon is investigated in vitro and in animal models to study chromatin unraveling, gene expression regulation in hepatocytes, reduction of oxidative stress, immune system modulation, and tissue preservation in hepatic injury models.
Is Vilon approved for human clinical use or liver disease treatment?
No. Vilon sold by PX1 Research is strictly designated for laboratory research use only. It is not intended for human or animal consumption, therapeutic administration, clinical diagnosis, or medical treatment.
How does PX1 Research verify the purity of Vilon batches?
PX1 Research utilizes an independent ISO 17025 accredited laboratory to verify each batch using Reverse-Phase HPLC (RP-HPLC) for chemical purity (>98.0%), Mass Spectrometry for molecular identity, and LAL testing for endotoxin levels.
How should reconstituted Vilon be stored in the laboratory?
Reconstituted Vilon solution should be aliquoted and stored at -80°C for long-term stability. Short-term storage at 4°C is acceptable for up to 7 days. Repeated freeze-thaw cycles should be strictly avoided.
Where does PX1 Research ship Vilon orders from?
All PX1 Research compounds are manufactured in domestic USA facilities and dispatched directly from fulfillment centers located in California and Arizona, with same-day shipping available for orders placed Monday through Friday before cutoff times.
What compounds are comparable to Vilon for tissue bioregulation research?
Comparable research compounds include Epitalon (studied for telomerase and endocrine regulation) and Thymogen (studied for thymic and T-cell immunomodulation). Both are short-chain bioregulatory peptides.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.